Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc. (CPHRF) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
cphrf · stock forecast · 1 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 1 Wall Street analysts in the past 3 months
Buy
1 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $12.14
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $11.93 | ↓ 1.72% |
1-day model range: $11.88–$11.99. Peak: $11.99 (-1.72%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $17 | +38.4% |
| 2028 | $20 | +67.6% |
| 2029 | $23 | +87.1% |
| 2030 | $24 | +99.0% |
| 2031 | — | +106.0% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CPHRF · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2023-06-01 | Stifel | Upgrade ↑ | Hold→Speculative Buy |
Wall Street analysts have recently issued updated ratings on Cipher Pharmaceuticals Inc. (CPHRF) stock. Of the recent 1 rating actions, 1 were upgrades and 0 were downgrades. 1 analysts currently cover CPHRF.
Analyst Recommendation Trends
CPHRF analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$53M
↓ 18.2% YoY
Revenue Next Year
$62M
↑ 15.7% YoY
EPS This Year
$0.90
EPS Next Year
$1.01
↑ 12.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast CPHRF EPS of $0.90 for the current fiscal year, based on estimates from 4 analysts. The CPHRF revenue forecast is $53M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CPHRF stock forecast is supported by two independent data sources: analyst consensus ratings from 1 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CPHRF price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The CPHRF short-term stock prediction for tomorrow is $11.93 (-1.72%). The CPHRF stock price prediction for 2027 estimates an average of $17. The CPHRF stock prediction for 2030 projects a range of $23–$25.
Cipher Pharmaceuticals Inc. trades on OTC under the ticker CPHRF. The CPHRF stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
CPHRF forecast · 8 questionsAccording to 1 Wall Street analysts, the average 12-month CPHRF price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $12.14.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.